Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Enterprise Value (2020 - 2025)

iSpecimen has reported Enterprise Value over the past 6 years, most recently at -$6.9 million for Q4 2025.

  • Quarterly results put Enterprise Value at -$6.9 million for Q4 2025, down 266.31% from a year ago — trailing twelve months through Dec 2025 was -$6.9 million (down 266.31% YoY), and the annual figure for FY2025 was -$6.9 million, down 266.31%.
  • Enterprise Value for Q4 2025 was -$6.9 million at iSpecimen, down from -$2.8 million in the prior quarter.
  • Over the last five years, Enterprise Value for ISPC hit a ceiling of -$588775.0 in Q2 2025 and a floor of -$27.7 million in Q4 2021.
  • Median Enterprise Value over the past 5 years was -$6.9 million (2025), compared with a mean of -$9.8 million.
  • Biggest five-year swings in Enterprise Value: crashed 3886.01% in 2021 and later skyrocketed 76.81% in 2024.
  • iSpecimen's Enterprise Value stood at -$27.7 million in 2021, then skyrocketed by 44.81% to -$15.3 million in 2022, then soared by 67.3% to -$5.0 million in 2023, then soared by 62.47% to -$1.9 million in 2024, then tumbled by 266.31% to -$6.9 million in 2025.
  • The last three reported values for Enterprise Value were -$6.9 million (Q4 2025), -$2.8 million (Q3 2025), and -$588775.0 (Q2 2025) per Business Quant data.